Provided by Tiger Fintech (Singapore) Pte. Ltd.

DELCATH SYSTEMS INC

11.63
+0.08000.69%
Post-market: 11.630.00000.00%18:31 EDT
Volume:315.09K
Turnover:3.67M
Market Cap:388.48M
PE:-12.57
High:11.84
Open:11.53
Low:11.36
Close:11.55
Loading ...

Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma

Business Wire
·
10 Apr

Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference

Business Wire
·
25 Mar

BRIEF-Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
15 Mar

Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
15 Mar

With A 27% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For

Simply Wall St.
·
11 Mar

Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.
·
08 Mar

Delcath Systems Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
07 Mar

Delcath Systems price target raised to $24 from $22 at H.C. Wainwright

TIPRANKS
·
07 Mar

Delcath Systems, Inc. : H.c. Wainwright Raises Target Price to $24 From $22

THOMSON REUTERS
·
07 Mar

Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation

Simply Wall St.
·
07 Mar

Delcath Systems Braces for Financial Impact Amid Uncertain Tax Law Changes

TIPRANKS
·
07 Mar

Delcath Systems Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

Delcath Systems Q4 2024 GAAP EPS $(0.11) Misses $(0.02) Estimate, Sales $15.10M Beat $13.78M Estimate

Benzinga
·
06 Mar

Delcath Systems Reports Fourth Quarter and Full Year 2024 Results

Business Wire
·
06 Mar

Delcath Systems Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
04 Mar

BRIEF-Delcath Systems Announces Update To National Comprehensive Cancer Network Clinical Practice Guidelines

Reuters
·
14 Feb

Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma

THOMSON REUTERS
·
14 Feb

Delcath Systems: Updated Nccn Guidelines Include Hepzato Kit as Category 2a Treatment for Patients With Hepatic-Dominant Uveal Melanoma

THOMSON REUTERS
·
14 Feb

Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma

Business Wire
·
14 Feb

Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Business Wire
·
29 Jan